ICON PLC (ICLR) Fundamental Analysis & Valuation
NASDAQ:ICLR • IE0005711209
Current stock price
110.37 USD
+3.56 (+3.33%)
At close:
110 USD
-0.37 (-0.34%)
After Hours:
This ICLR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ICLR Profitability Analysis
1.1 Basic Checks
- In the past year ICLR was profitable.
- In the past year ICLR had a positive cash flow from operations.
- In the past 5 years ICLR has always been profitable.
- ICLR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of ICLR (3.63%) is better than 75.44% of its industry peers.
- ICLR has a better Return On Equity (6.42%) than 75.44% of its industry peers.
- The Return On Invested Capital of ICLR (6.74%) is better than 78.95% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for ICLR is significantly below the industry average of 11.38%.
- The 3 year average ROIC (5.80%) for ICLR is below the current ROIC(6.74%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 6.42% | ||
| ROIC | 6.74% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
1.3 Margins
- With a decent Profit Margin value of 7.40%, ICLR is doing good in the industry, outperforming 73.68% of the companies in the same industry.
- In the last couple of years the Profit Margin of ICLR has declined.
- With a decent Operating Margin value of 13.99%, ICLR is doing good in the industry, outperforming 75.44% of the companies in the same industry.
- ICLR's Operating Margin has been stable in the last couple of years.
- The Gross Margin of ICLR (28.15%) is worse than 77.19% of its industry peers.
- In the last couple of years the Gross Margin of ICLR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.99% | ||
| PM (TTM) | 7.4% | ||
| GM | 28.15% |
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
2. ICLR Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICLR is destroying value.
- ICLR has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, ICLR has more shares outstanding
- Compared to 1 year ago, ICLR has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 1.63, we must say that ICLR is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of ICLR (1.63) is comparable to the rest of the industry.
- ICLR has a debt to FCF ratio of 3.53. This is a good value and a sign of high solvency as ICLR would need 3.53 years to pay back of all of its debts.
- ICLR has a better Debt to FCF ratio (3.53) than 77.19% of its industry peers.
- ICLR has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
- Looking at the Debt to Equity ratio, with a value of 0.31, ICLR is in line with its industry, outperforming 49.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 3.53 | ||
| Altman-Z | 1.63 |
ROIC/WACC0.81
WACC8.29%
2.3 Liquidity
- ICLR has a Current Ratio of 1.06. This is a normal value and indicates that ICLR is financially healthy and should not expect problems in meeting its short term obligations.
- ICLR has a worse Current ratio (1.06) than 87.72% of its industry peers.
- A Quick Ratio of 1.06 indicates that ICLR should not have too much problems paying its short term obligations.
- The Quick ratio of ICLR (1.06) is worse than 80.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 |
3. ICLR Growth Analysis
3.1 Past
- ICLR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.99%.
- Measured over the past years, ICLR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.23% on average per year.
- Looking at the last year, ICLR shows a decrease in Revenue. The Revenue has decreased by -2.46% in the last year.
- Measured over the past years, ICLR shows a very strong growth in Revenue. The Revenue has been growing by 24.17% on average per year.
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
3.2 Future
- The Earnings Per Share is expected to grow by 2.14% on average over the next years.
- The Revenue is expected to grow by 1.48% on average over the next years.
EPS Next Y-5.55%
EPS Next 2Y-4.76%
EPS Next 3Y-0.27%
EPS Next 5Y2.14%
Revenue Next Year-2.68%
Revenue Next 2Y-1.75%
Revenue Next 3Y0.18%
Revenue Next 5Y1.48%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. ICLR Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 8.37 indicates a reasonable valuation of ICLR.
- Based on the Price/Earnings ratio, ICLR is valued cheaper than 98.25% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.18, ICLR is valued rather cheaply.
- ICLR is valuated reasonably with a Price/Forward Earnings ratio of 8.69.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ICLR indicates a rather cheap valuation: ICLR is cheaper than 100.00% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 37.96, ICLR is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.37 | ||
| Fwd PE | 8.69 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ICLR is valued cheaper than 98.25% of the companies in the same industry.
- ICLR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ICLR is cheaper than 98.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.74 | ||
| EV/EBITDA | 7.47 |
4.3 Compensation for Growth
- The decent profitability rating of ICLR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.55
EPS Next 2Y-4.76%
EPS Next 3Y-0.27%
5. ICLR Dividend Analysis
5.1 Amount
- ICLR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ICLR Fundamentals: All Metrics, Ratios and Statistics
110.37
+3.56 (+3.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-22 2025-10-22/amc
Earnings (Next)04-29 2026-04-29/amc
Inst Owners110.05%
Inst Owner Change2.58%
Ins Owners0.66%
Ins Owner Change0%
Market Cap8.43B
Revenue(TTM)8.10B
Net Income(TTM)599.48M
Analysts75
Price Target152.55 (38.22%)
Short Float %3.82%
Short Ratio1.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.77%
Min EPS beat(2)-1.21%
Max EPS beat(2)-0.34%
EPS beat(4)1
Avg EPS beat(4)-0.63%
Min EPS beat(4)-1.21%
Max EPS beat(4)0.23%
EPS beat(8)1
Avg EPS beat(8)-2.34%
EPS beat(12)2
Avg EPS beat(12)-1.79%
EPS beat(16)5
Avg EPS beat(16)-1.4%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.61%
Max Revenue beat(4)1.03%
Revenue beat(8)1
Avg Revenue beat(8)-2.24%
Revenue beat(12)1
Avg Revenue beat(12)-2.14%
Revenue beat(16)1
Avg Revenue beat(16)-2.06%
PT rev (1m)-4.36%
PT rev (3m)-27.24%
EPS NQ rev (1m)-0.68%
EPS NQ rev (3m)-2.87%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-0.9%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)-0.68%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.37 | ||
| Fwd PE | 8.69 | ||
| P/S | 1.04 | ||
| P/FCF | 8.74 | ||
| P/OCF | 7.39 | ||
| P/B | 0.9 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.47 |
EPS(TTM)13.19
EY11.95%
EPS(NY)12.7
Fwd EY11.5%
FCF(TTM)12.63
FCFY11.44%
OCF(TTM)14.93
OCFY13.53%
SpS106.11
BVpS122.25
TBVpS-38.98
PEG (NY)N/A
PEG (5Y)0.55
Graham Number190.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 6.42% | ||
| ROCE | 8.53% | ||
| ROIC | 6.74% | ||
| ROICexc | 6.98% | ||
| ROICexgc | 176.34% | ||
| OM | 13.99% | ||
| PM (TTM) | 7.4% | ||
| GM | 28.15% | ||
| FCFM | 11.9% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ROICexc(3y)5.97%
ROICexc(5y)8.67%
ROICexgc(3y)88.82%
ROICexgc(5y)90.84%
ROCE(3y)7.34%
ROCE(5y)8.76%
ROICexgc growth 3Y-4.45%
ROICexgc growth 5Y-5.01%
ROICexc growth 3Y27.99%
ROICexc growth 5Y-24.17%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
F-Score6
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 3.53 | ||
| Debt/EBITDA | 1.89 | ||
| Cap/Depr | 45.31% | ||
| Cap/Sales | 2.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.92% | ||
| Profit Quality | 160.84% | ||
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z | 1.63 |
F-Score6
WACC8.29%
ROIC/WACC0.81
Cap/Depr(3y)27.79%
Cap/Depr(5y)38.09%
Cap/Sales(3y)1.87%
Cap/Sales(5y)1.83%
Profit Quality(3y)130.43%
Profit Quality(5y)205.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
EPS Next Y-5.55%
EPS Next 2Y-4.76%
EPS Next 3Y-0.27%
EPS Next 5Y2.14%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
Revenue Next Year-2.68%
Revenue Next 2Y-1.75%
Revenue Next 3Y0.18%
Revenue Next 5Y1.48%
EBIT growth 1Y-0.88%
EBIT growth 3Y26.12%
EBIT growth 5Y22.99%
EBIT Next Year0.06%
EBIT Next 3Y-0.04%
EBIT Next 5Y2.03%
FCF growth 1Y86.71%
FCF growth 3Y15.01%
FCF growth 5Y25.32%
OCF growth 1Y72.39%
OCF growth 3Y15.78%
OCF growth 5Y25.55%
ICON PLC / ICLR Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for ICON PLC?
ChartMill assigns a fundamental rating of 5 / 10 to ICLR.
What is the valuation status for ICLR stock?
ChartMill assigns a valuation rating of 7 / 10 to ICON PLC (ICLR). This can be considered as Undervalued.
What is the profitability of ICLR stock?
ICON PLC (ICLR) has a profitability rating of 6 / 10.
Can you provide the financial health for ICLR stock?
The financial health rating of ICON PLC (ICLR) is 4 / 10.